Direxion Daily Pharmaceutical & Medical Bull 3X Shares
Direxion Shares ETF Trust
+11
New
-4
Exited
53
Positions
| # | Name | Ticker | Since | Shares | Shares Δ | Value | Val Δ% | % Port | Cat |
|---|---|---|---|---|---|---|---|---|---|
| 1 | DREYFUS GOVERNMENT CASH MANAGE | N/A | Apr 2024 | 2,931,480 | +2,050,885 | $2.9M | +232.9% | 17.02% | STIV |
| 2 | GOLDMAN SACHS LIQ ES FD A | N/A | Apr 2024 | 1,450,595 | New | $1.5M | — | 8.42% | STIV |
| 3 | N/A | N/A | Apr 2024 | 1 | New | $947K | — | 5.50% | DE |
| 4 | GOLDMAN FINANCIAL | N/A | Apr 2024 | 677,913 | New | $678K | — | 3.94% | STIV |
| 5 | N/A | N/A | Apr 2024 | 1 | New | $534K | — | 3.10% | DE |
| 6 | Axsome Therapeutics Inc. | AXSM | Apr 2024 | 6,047 | -738 | $528K | +5.5% | 3.06% | EC |
| 7 | Viatris Inc | VTRS | Apr 2024 | 43,775 | +2,866 | $528K | +11.5% | 3.06% | EC |
| 8 | Intra-Cellular Therapies Inc | ITCI | Apr 2024 | 6,569 | -863 | $517K | -3.1% | 3.00% | EC |
| 9 | Bristol-Myers Squibb Company | BMY | Apr 2024 | 10,806 | +1,482 | $514K | +25.4% | 2.98% | EC |
| 10 | Pfizer Inc. | PFE | Apr 2024 | 16,171 | -2,255 | $494K | +4.6% | 2.87% | EC |
| 11 | Corcept Therapeutics Inc. | CORT | Apr 2024 | 12,633 | -2,752 | $489K | +36.2% | 2.84% | EC |
| 12 | Johnson & Johnson | JNJ | Apr 2024 | 3,059 | -85 | $483K | +6.2% | 2.80% | EC |
| 13 | Organon & Co | OGN | Apr 2024 | 21,823 | -5,361 | $477K | -5.7% | 2.77% | EC |
| 14 | Catalent Inc | CTLT | Apr 2024 | 8,026 | -850 | $476K | -3.9% | 2.76% | EC |
| 15 | Zoetis Inc. | ZTS | Apr 2024 | 2,611 | -142 | $470K | +7.2% | 2.73% | EC |
| 16 | Perrigo Company PLC | PRGO | Apr 2024 | 16,581 | +258 | $469K | -12.1% | 2.72% | EC |
| 17 | Royalty Pharma PLC | RPRX | Apr 2024 | 16,536 | +22 | $466K | +1.8% | 2.70% | EC |
| 18 | Jazz Pharmaceuticals PLC | JAZZ | Apr 2024 | 3,943 | -324 | $435K | -8.0% | 2.52% | EC |
| 19 | Eli Lilly & Co. | LLY | Apr 2024 | 507 | -151 | $408K | -20.7% | 2.37% | EC |
| 20 | Arvinas Inc | ARVN | Apr 2024 | 14,438 | +6,444 | $397K | +56.4% | 2.31% | EC |
| 21 | Merck & Co., Inc | MRK | Apr 2024 | 3,439 | -622 | $389K | -25.9% | 2.26% | EC |
| 22 | N/A | N/A | Apr 2024 | 1 | New | $386K | — | 2.24% | DE |
| 23 | Ocular Therapeutix Inc | OCUL | Apr 2024 | 39,434 | +31,743 | $334K | +815.1% | 1.94% | EC |
| 24 | Elanco Animal Health Inc | ELAN | Apr 2024 | 24,691 | -5,799 | $322K | -19.8% | 1.87% | EC |
| 25 | Prestige Consumer Healthcare Inc | PBH | Apr 2024 | 4,049 | +1,926 | $287K | +88.2% | 1.66% | EC |
| 26 | Amphastar Pharmaceuticals Inc | AMPH | Apr 2024 | 6,360 | +1,004 | $277K | +25.3% | 1.61% | EC |
| 27 | Cassava Sciences Inc | SAVA | Apr 2024 | 12,427 | +2,569 | $276K | +26.5% | 1.60% | EC |
| 28 | Collegium Pharmaceutical Inc. | COLL | Apr 2024 | 6,962 | +3,758 | $269K | +126.9% | 1.56% | EC |
| 29 | Ligand Pharmaceuticals Incorporated | LGND | Apr 2024 | 2,302 | +1,131 | $251K | +206.6% | 1.46% | EC |
| 30 | Supernus Pharmaceuticals, Inc | SUPN | Apr 2024 | 8,405 | +5,322 | $251K | +170.1% | 1.45% | EC |
| 31 | Longboard Pharmaceuticals Inc | LBPH | Apr 2024 | 6,387 | +87 | $212K | +58.2% | 1.23% | EC |
| 32 | Tarsus Pharmaceuticals Inc | TARS | Apr 2024 | 8,259 | +2,856 | $201K | +18.1% | 1.16% | EC |
| 33 | Harmony Biosciences Holdings Inc | HRMY | Apr 2024 | 5,896 | +1,786 | $200K | +57.1% | 1.16% | EC |
| 34 | Mind Medicine (MindMed) Inc. | MNMD | Jul 2024 | 19,098 | New | $177K | — | 1.03% | EC |
| 35 | ANI Pharmaceuticals Inc. | ANIP | Apr 2024 | 2,620 | +1,614 | $172K | +159.3% | 1.00% | EC |
| 36 | Pacira Biosciences Inc | PCRX | Apr 2024 | 8,196 | +3,359 | $169K | +33.3% | 0.98% | EC |
| 37 | Edgewise Therapeutics Inc. | EWTX | Jul 2024 | 9,799 | New | $167K | — | 0.97% | EC |
| 38 | Innoviva Inc | INVA | Apr 2024 | 8,568 | +1,329 | $161K | +47.6% | 0.94% | EC |
| 39 | Liquidia Corporation | LQDA | Apr 2024 | 13,073 | +4,946 | $156K | +49.3% | 0.91% | EC |
| 40 | Amneal Pharmaceuticals Inc | AMRX | Apr 2024 | 19,040 | +4,070 | $140K | +54.1% | 0.81% | EC |
| 41 | Evolus Inc | EOLS | Apr 2024 | 10,720 | +6,626 | $133K | +176.3% | 0.77% | EC |
| 42 | EyePoint Pharmaceuticals Inc. | EYPT | Apr 2024 | 11,607 | -359 | $115K | -45.5% | 0.67% | EC |
| 43 | Harrow Inc | HROW | Jul 2024 | 4,338 | New | $112K | — | 0.65% | EC |
| 44 | Enliven Therapeutics Inc | ELVN | Jul 2024 | 3,599 | New | $95K | — | 0.55% | EC |
| 45 | Pliant Therapeutics Inc. | PLRX | Apr 2024 | 6,462 | +1,483 | $92K | +57.1% | 0.54% | EC |
| 46 | Fulcrum Therapeutics Inc | FULC | Apr 2024 | 9,529 | +5,568 | $88K | +213.1% | 0.51% | EC |
| 47 | Nuvation Bio Inc | NUVB | Jul 2024 | 17,852 | New | $68K | — | 0.40% | EC |
| 48 | Wave Life Sciences Ltd. | WVE | Jul 2024 | 8,935 | New | $59K | — | 0.34% | EC |
| 49 | Xeris Biopharma Holdings Inc | XERS UW | Apr 2024 | 21,567 | +593 | $53K | +45.7% | 0.31% | EC |
| ✕ | Amylyx Pharmaceuticals Inc | 03237H101 | — | 52,603 | Exited | $0.1M | — | — | — |
| ✕ | Revance Therapeutics Inc | 761330109 | — | 17,130 | Exited | $0.1M | — | — | — |
| ✕ | Theravance Biopharma Inc | G8807B106 | — | 4,334 | Exited | $0.0M | — | — | — |
| ✕ | Marinus Pharmaceuticals Inc | 56854Q200 | — | 4,705 | Exited | $0.0M | — | — | — |